(Q36080314)

English

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC) (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Schlumberger M

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Abdelmoumene N

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Delisle MJ

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Couette JE

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 February 1995

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

363-365

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033569

2 October 2017

Therapy of malignant APUD cell tumors: Effectiveness of DTIC

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033569

2 October 2017

Doxorubicin plus cisplatin in the treatment of apudomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033569

2 October 2017

Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033569

27 July 2018

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033569

23 September 2018

Failure of Medullary Carcinoma of the Thyroid to Respond to Doxorubicin Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1995.73

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36080314&oldid=2198169570"